Documentos de Dans A.L. | REDI

Regresar

Mostrando 3 resultados de: 3

Filtros aplicados

Área temáticas: "Medicina y salud"

Subtipo de publicación

Publisher

European Heart Journal - Quality of Care and Clinical Outcomes(1)

The Lancet Respiratory Medicine(1)

Área temáticas

Enfermedades(2)

Farmacología y terapéutica(2)

Problemas sociales y servicios a grupos(2)

Área de conocimiento

Ensayo clínico(2)

Medicina interna(2)

Farmacología(1)

Año de Publicación

Origen

Palabras Claves

Cardiovascular disease(1)

Primary Prevention(1)

cost analysis(1)

Colchicine and aspirin in community patients with COVID-19 (ACT): an open-label, factorial, randomised, controlled trial

Abstract: Background: The large number of patients worldwide infected with the SARS-CoV-2 virus has overwhelme

Palabras claves:

Ali Z., Anand S.S., Avezum A.J., Bangdiwala S.I., Belley-Cote E.P., Berwanger O., Bosch J.J., Choudhri S., Dans A.L., Eikelboom J.W., Farkouh M.E., Felix Camilo, Harper W.L., Hassany M., Heenan L., Jolly S.S., Kontsevaya A., Loeb M., Lopes R.D., Pais P., Palileo-Villanueva L.M., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Sharma S.K., Tarhuni W.M., Wasserman S., Whitlock R.P., Xavier D., Xu L., Yusuf S., Yusufali A.M.

The Anti-Coronavirus Therapies (ACT) Trials: Design, Baseline Characteristics, and Challenges

Abstract: Background: Effective treatments for COVID-19 are urgently needed, but conducting randomized trials

Palabras claves:

Anand S.S., Avezum A.J., Bangdiwala S.I., Belley-Cote E.P., Beresh H., Berwanger O., Bosch J.J., Chan N., Choudhri S., Dans A.L., DIaz R., Eikelboom J.W., Farkouh M.E., Felix Camilo, Harper W.L., Hassany M., Jolly S.S., Kazmi K., Kontsevaya A., Lewis G., Loeb M., Lopes R.D., Nkeshimana M., Orlandini A., Pais P., PATRICIO LOPEZ -JARAMILLO, Rangarajan S., Sharma S.K., Tarhuni W.M., Wasserman S., Whitlock R.P., Xavier D., Xu L., Yusuf S., Yusufali A.M.

The cost implications of a polypill for primary prevention in the TIPS-3 trial

Abstract: Aims The International Polycap Study 3 (TIPS-3) trial demonstrated that a polypill containing choles

Palabras claves:

Cardiovascular disease, cost analysis, Polypill, Primary Prevention

Dans A.L., Gamra H., Gao P., Joseph P.G., Lamy A., Pais P., PATRICIO LOPEZ -JARAMILLO, Santoso A., Talukder S.H., Tong W., Walli-Attaei M., Xavier D., Yusuf S.